Canada · Delayed Price · Currency is CAD Lobe Sciences Statistics
Total Valuation
Lobe Sciences has a market cap or net worth of CAD 13.47 million. The enterprise value is 8.95 million.
| Market Cap | 13.47M |
| Enterprise Value | 8.95M |
Important Dates
The last earnings date was Wednesday, January 28, 2026.
| Earnings Date | Jan 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Lobe Sciences has 269.49 million shares outstanding. The number of shares has increased by 11.19% in one year.
| Current Share Class | 269.49M |
| Shares Outstanding | 269.49M |
| Shares Change (YoY) | +11.19% |
| Shares Change (QoQ) | +13,431.57% |
| Owned by Insiders (%) | 19.54% |
| Owned by Institutions (%) | n/a |
| Float | 157.55M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 3.59 |
| P/TBV Ratio | 8.66 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.97 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.33, with a Debt / Equity ratio of 0.08.
| Current Ratio | 2.33 |
| Quick Ratio | 2.32 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -29.71 |
Financial Efficiency
Return on equity (ROE) is -3,651.86% and return on invested capital (ROIC) is -250.13%.
| Return on Equity (ROE) | -3,651.86% |
| Return on Assets (ROA) | -87.19% |
| Return on Invested Capital (ROIC) | -250.13% |
| Return on Capital Employed (ROCE) | -123.12% |
| Weighted Average Cost of Capital (WACC) | 3.77% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +66.67% in the last 52 weeks. The beta is -0.25, so Lobe Sciences's price volatility has been lower than the market average.
| Beta (5Y) | -0.25 |
| 52-Week Price Change | +66.67% |
| 50-Day Moving Average | 0.05 |
| 200-Day Moving Average | 0.04 |
| Relative Strength Index (RSI) | 48.38 |
| Average Volume (20 Days) | 68,518 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -4.98M |
| Pretax Income | -5.37M |
| Net Income | -4.54M |
| EBITDA | n/a |
| EBIT | -4.98M |
| Earnings Per Share (EPS) | -0.03 |
Balance Sheet
The company has 7.02 million in cash and 295,679 in debt, with a net cash position of 6.72 million or 0.02 per share.
| Cash & Cash Equivalents | 7.02M |
| Total Debt | 295,679 |
| Net Cash | 6.72M |
| Net Cash Per Share | 0.02 |
| Equity (Book Value) | 3.75M |
| Book Value Per Share | 0.01 |
| Working Capital | 4.05M |
Cash Flow
| Operating Cash Flow | -1.75M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Lobe Sciences does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -11.19% |
| Shareholder Yield | -11.19% |
| Earnings Yield | -33.72% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 10, 2022. It was a reverse split with a ratio of 0.166666667.
| Last Split Date | Jun 10, 2022 |
| Split Type | Reverse |
| Split Ratio | 0.166666667 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |